Fatty acid and water-soluble polymer-based controlled release drug delivery system

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1900-1912

  Desai, Divyakant ^a   Kothari, Sanjeev ^b   Chen, Wei ^a   Wang, Jennifer ^a   Huang, Ming ^a   Sharma, Laxmikant ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b GENENTECH INC   (United States)

Author keywords

Diffusion; Dissolution; Dissolution rate; Excipients; Formulation; Oral drug delivery; Polymeric drug delivery systems; Solid dosage form

Indexed keywords

FATTY ACID; GLIPIZIDE; HYDROXYPROPYLCELLULOSE; LAURIC ACID; PARACETAMOL; POLYMER; POVIDONE; STEARIC ACID; THEOPHYLLINE;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; HUMIDITY;

EID: 79952205433     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22397     Document Type: Article

References (22)

1. Wen H, Park K. 2010. Oral controlled release formulation design and drug delivery: Theory to practice. Wiley, Hoboken, NJ.
2. Chien W. 1982. Novel drug delivery systems. Marcel Dekker, Inc. New York, NY.
3. Fan L, Singh S. 1989. Controlled release: A quantitative treatment. Springer-Verlag, New York, NY.
4. Khan GM, Jiabi Z. 1998. Formulation and in-vitro evaluation of ibuprofen-carbopol® 974P-NF controlled release matrix tablets III: Influence of co-excipients on release rate of the drug. J Control Release 54:185-190.
5. Streubel A, Siepmann J, Dashevsky A, Bodmeier R. 2000. pH-independent release of a weakly basic drug from water-insoluble and-soluble matrix tablets. J Control Release 67:101-110.
6. Qiu L, Bae Y. 2006. Polymer architecture and drug delivery. Pharm Res 23:1-30.
7. Siepmann F, Siepmann J, Walther M, MacRae R, Bodmeier R. 2008. Polymer blends for controlled release coatings. J Control Release 125:1-15.
8. Karrout Y, Neut C, Wils D, Siepmann F, Deremaux L, Desreumaux P, Siepmann J. 2009. Novel polymeric film coatings for colon targeting: How to adjust desired membrane properties. Int J Pharm 371:64-70.
9. Alvarez-Lorenzo C, Castro E, Gomez-Amoza J, Martinez-Pacheco R, Souto C, Concheiro A. 1998. Intersupplier and interlot variability in hydroxypropyl celluloses: Implications for theophylline release from matrix tablets. Pharm Acta Helv 73:113-120.
10. Perze-Marcos B, Martinze-Pacheco R, Gomez-Amoza J, Souto C, Concheiro A, Rowe R. 1993. Interlot variability of carbomer 934. Int J Pharm 100:207-212.
11. Siepmann F, Eckart K, Maschke A, Kotler K, Siepmann J. 2010. Modeling drug release from PVAc/PVP matrix tablets. J Control Release 141:216-222.
12. Siepmann J, Podul K, Sriwongjaya N, Peppas N, Bodmeier R. 1999. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J Pharm Sci 88:65-72.
13. Fluent Incorporated. 2006. Fluent 6.3 document. Canonsburg, PA.
14. Desai D, Kothari S, Huang M. 2008. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules. Int J Pharm 354:77-81.
15. The Merck index. 1976. 14th ed. Merck & Co., Whitehouse Station, NJ.
16. Jamzad S, Fassihi R. 2006. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide-A technical note AAPS PharmSciTech 7(2).
17. Paruta AN, Sciarrone BJ, Lordi NG. 1965. Solubility profiles for the xanthines in dioxane-water mixtures. J Pharm Sci 54:838-841.
18. Granberg R, Rasmuson A. 1999. Solubility of paracetamol in pure solvents. J Chem Eng Data 44:1391-1395.
19. Fatty acids. At: on April 3, 2010.
20. Morrison R, Boyd R. 1987. Organic chemistry. 5th ed. Allyn and Bacon, Inc., pp 819.
21. Wade A, Weller P, Eds. 1994. Handbook of pharmaceutical excipients. 2nd ed. The Pharmaceutical Press.
22. Khuwijitjaru P, Adachi S, Matsuno R. 2002. Solubility of saturated fatty acids in water at elevated temperature. Biosci Biotechnol Biochem 66:1723-1726.